About EpiBiome
EpiBiome is a company based in San Francisco (United States) founded in 2013 was acquired by Locus Biosciences in July 2018.. EpiBiome has raised $6 million across 6 funding rounds from investors including Illumina, SVB and ARE. EpiBiome operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Amyris, Chimerix and Syngenta, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6 M (USD)
in 6 rounds
-
Latest Funding Round
$200 K (USD), Grant
Jun 01, 2017
-
Investors
Illumina
& 10 more
-
Employee Count
Employee Count
-
Acquired by
Locus Biosciences
(Jul 17, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of EpiBiome
EpiBiome has successfully raised a total of $6M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $200 thousand completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $200,000
- First Round First Round
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2017 | Amount | Grant - EpiBiome | Valuation |
investors |
|
| Jul, 2016 | Amount | Grant - EpiBiome | Valuation |
investors |
|
| Jun, 2016 | Amount | Debt – Venture - EpiBiome | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in EpiBiome
EpiBiome has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Illumina, SVB and ARE. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated by Stanford-backed program in Palo Alto.
|
Founded Year | Domain | Location | |
|
Early-stage ventures are funded by the investment firm.
|
Founded Year | Domain | Location | |
|
Private investment firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EpiBiome
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - EpiBiome
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Epibiome Comparisons
Competitors of EpiBiome
EpiBiome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Amyris, Chimerix and Syngenta, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Antiviral oral therapeutics are developed for infectious diseases and cancers.
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Epibiome
Frequently Asked Questions about EpiBiome
When was EpiBiome founded?
EpiBiome was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is EpiBiome located?
EpiBiome is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is EpiBiome a funded company?
EpiBiome is a funded company, having raised a total of $6M across 6 funding rounds to date. The company's 1st funding round was a Debt – Venture of $1M, raised on Oct 15, 2014.
What does EpiBiome do?
EpiBiome was founded in 2013 and is headquartered in San Francisco, United States. Antibiotics and phage-based therapeutics are developed by the company for applications in agriculture and human health. Large-scale automation, bioinformatics, and algorithmic methods are employed to create targeted treatments against pathogens, including those resistant to conventional antibiotics. Operations focus on precision in eliminating bacterial threats without broad-spectrum effects.
Who are the top competitors of EpiBiome?
EpiBiome's top competitors include Moderna, Syngenta and Adaptive Biotechnologies.
Who are EpiBiome's investors?
EpiBiome has 11 investors. Key investors include Illumina, SVB, ARE, Locus Biosciences, and Gates Foundation.